AS raises #cardiovascular risk through accelerated atherosclerosis, driven by inflammation and endothelial dysfunction. The role of adhesion molecules like ICAM-1 and VCAM-1 as predictors of CV events is undeniable. #ankylosing#AxSpA#CVrisk
Fulltext: 👉https://t.co/RVzCrveOaD
METFORMIN AS A PROMISING ANTI-AGING AGENT IN THE TREATMENT OF OSTEOARTHRITIS | Anti-Aging Eastern Europe
@GeorgievMD@OsteoarthritisM@RheumaFactor
https://t.co/NlYfvebXr3
🔥The June 2024 issue of AAEEu has been published at https://t.co/zW5cQvGZZB
It contains valuable reviews on #nutrition therapy, psychological interventions, #PainManagement, and other articles of interest to GPs, #rehabilitation, and #geriatrics specialists.
POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE | Anti-Aging Eastern Europe https://t.co/HhMIPuINZe
Uncover the evolving realm of Axial Spondyloarthritis (axSpA)! 🌟 From genetic insights to inflammatory pathways and therapeutic breakthroughs, explore the landscape shaping this chronic rheumatic disease. #axSpA#rheumatology#immunology#research
https://t.co/4SISOqjkx6
🔥#EULAR 2023 #osteoarthritis RECs focus on a holistic approach, advocating personalized, multicomponent plans. They prioritize individual needs and shared decision-making. 🗝️ aspects include adapting exercises, self-management, and work-related factors.
https://t.co/bvhzntkgQ6
By comprehensively reviewing the current evidence and research gaps, my newest article provides valuable insights into the interplay between #PCOS, #aging, and #fertility, paving the way for optimized clinical approaches and future advancements.
https://t.co/kCTup1eyGH
Our review with @AngelovMD on inflamm. arthritis & CVD is 🔥 off the press, focusing on #glycocalyx in early #atherosclerosis. Mediators, immune cells, microparticles, microRNA, and syndecans influence dynamic systemic-endothelial interplay. Fulltext at https://t.co/jaVxHrjUQs
#Repurposing drugs for #osteoarthritis with the potential to reduce cell senescence is a justified therapeutic strategy. Such is the case of #metformin, the most widely used antidiabetic medicine with well-known pharmacokinetics.
https://t.co/n13oO093fp
📷 Exciting findings reveal the importance of individualizing #rituximab treatment for #ANCA-associated #vasculitis! Monitoring rituximab levels and genetics can optimize outcomes. Tailoring treatment for better results! #Rheumatology#MedicalResearch
https://t.co/nxM7Jifv7C
Our newest review with @PKabakchieva on the diverse pleiotropic effects of #metformin focuses on #osteoarthritis. The full-text article could be found at https://t.co/n13oO093fp
And yes: metformin could be repurposed for osteoarthritis treatment.
Non-Pharmaceutical Interventions Reduce the Incidence, and Mortality of COVID-19: A Study based on the Survey from the International COVID-19 Research Network (ICRN)
https://t.co/qAO5NDx5eK
Randomized, double-blind, placebo-controlled trial indicated that use of 3mg liraglutide, a GLP-1 agonist, resulted in greater loss in weight & decrease in free androgen index during a 32-week lifestyle intervention for women w/ #PCOS
Link: https://t.co/XuLwl6Mm7u